Related content

Transcriptomics of Antipsychotic Drug Function: What have we Learned from Rodent Studies?

By  

Current Psychopharmacology, Vol. 1, Iss. 4, 2012-11 ,pp. : 272-283

Bentham Science Publishers

Access to resources Recommend Favorite

Myc - What We have Learned from Flies

By  

Current Drug Targets, Vol. 10, Iss. 7, 2009-07 ,pp. : 590-601

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Non-Steroidal Anti-Inflammatory Drugs: What we have Learned from Animal Studies

By  

Current Drug Targets. Inflammation & Allergy, Vol. 3, Iss. 1, 2004-03 ,pp. : 43-61

Bentham Science Publishers

Access to resources Recommend Favorite

Neurotrophic Factors in Parkinson’s Disease: What Have we Learned from Pre-Clinical and Clinical Studies?

By  

Current Medicinal Chemistry, Vol. 25, Iss. 31, 2018-09 ,pp. : 3682-3702

Bentham Science Publishers

Access to resources Recommend Favorite

Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here?

By Urban Thomas J   Goldstein David B   Watkins Paul B  

Pharmacogenomics, Vol. 13, Iss. 7, 2012-05 ,pp. : 735-738

Future Medicine

Access to resources Recommend Favorite